Regarding the presently detected variants of pathogenic significance, melanoma was among the top 6 most common cancers to exhibit mutations in each of those genes (except BRCA2), which were not reported with significant frequency in rhabdomyosarcoma [9]. This evidence concerns the gene BRCA2 and melanoma.